tiprankstipranks
Advertisement
Advertisement

SE:CINPHA Stock Latest News

Cinclus Pharma AGM backs new share mandate and long-term incentive plan
Company AnnouncementsCinclus Pharma AGM backs new share mandate and long-term incentive plan
3d ago
Cinclus Pharma Publishes Q1 2026 Interim Report Highlighting Late-Stage Pipeline and Market Potential
PremiumCompany Announcements
Cinclus Pharma Publishes Q1 2026 Interim Report Highlighting Late-Stage Pipeline and Market Potential
12d ago
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
PremiumCompany Announcements
Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
26d ago
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
PremiumCompany Announcements
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
1M ago
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
PremiumCompany Announcements
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
2M ago
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
PremiumCompany AnnouncementsCinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
2M ago
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
Premium
Company Announcements
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
3M ago
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
Premium
Company Announcements
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
3M ago
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
PremiumCompany Announcements
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
3M ago
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
PremiumCompany Announcements
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
3M ago
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
PremiumCompany Announcements
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
4M ago
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
PremiumCompany Announcements
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
4M ago
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
PremiumCompany AnnouncementsCinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
5M ago
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
Premium
Company Announcements
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
6M ago
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
Premium
Company Announcements
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
6M ago
Cinclus Pharma Announces Extraordinary General Meeting
PremiumCompany Announcements
Cinclus Pharma Announces Extraordinary General Meeting
6M ago
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
PremiumCompany Announcements
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
6M ago
Cinclus Pharma Hosts Event on GERD Treatment Advancements
PremiumCompany Announcements
Cinclus Pharma Hosts Event on GERD Treatment Advancements
6M ago
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
PremiumCompany Announcements
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
6M ago
Cinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
PremiumCompany AnnouncementsCinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
6M ago
Cinclus Pharma Appoints 2026 AGM Nomination Committee
Premium
Company Announcements
Cinclus Pharma Appoints 2026 AGM Nomination Committee
6M ago
Cinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
Premium
Ratings
Cinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >